Ligand Pharmaceuticals Expands Senior Leadership Team With Two Key Hires
Feb 16, 2024•almost 2 years ago
Position
Senior Vice President of Clinical Development
Company
Ligand Pharmaceuticals Incorporated
Description
Ligand Pharmaceuticals Incorporated appoints Richard Baxter as Senior Vice President of Investment Operations and Karen Reeves, M.D. as Senior Vice President of Clinical Strategy and Investments, both reporting to CEO Todd Davis.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months